Genetic & Genomic MedicinemedRxivPreprint
Repurposing drugs for the prevention of vascular dementia: Evidence from drug target Mendelian randomization
Victoria Taylor‐Bateman, Phazha LK Bothongo, Venexia M. Walker…·Emma Louise Anderson
This paper uses Mendelian randomization to assess if existing drugs targeting lipid-lowering, anti-hypertensive, or anti-inflammatory pathways affect vascular dementia risk, finding potential benefits for beta-1 adrenergic receptor antagonists and risks for ACE inhibitors.
2 citations